Molecular Diagnostics
SARS-CoV-2 Molecular
For information on the program, material used, analytical parameters and the frequency of implementation, please refer to the current catalog.
Program: COVM: 4 surveys/year x 3 samples
Material: Liquid or lyophilized samples containing human epithel cells or fibroblasts as control for positive nucleic acid extraction and amplification. Virus-positive samples contain the whole genome of inactivated SARS-CoV-2, thus covering all possible gene targets used in different NAT/PCR assays (minimum 1 mL).
Evaluation: Qualitative and quantitative*
* The quantitative parameters are not accredited according to DIN EN ISO/ IEC 17043.
| SARS-CoV-2 RNA (qualitative) | SARS-CoV-2 RNA (quantitative) |
| General detection as well as reporting per gene target | General indication as well as reporting of quantitative value per gene target |
Instructions for Use
Result Entry Form
Molecular Diagnostics
HBV Molecular
For information on the program, material used, analytical parameters and the frequency of implementation, please refer to the current catalog.
Programme: BILI-N: 4 interlaboratory tests/year, 2 samples each
Material: Lyophilised samples from human serum (minimum 0.5 mL)
Evaluation: Quantitative
| Bilirubin direkt | Bilirubin total |
| Bilirubin konjugiert | Bilirubin unkonjugiert |
Instructions for Use
IFU_BILI_N, Ver_001
Result Entry Form
Ergebnisformular_BILI-N